American Society of Hematology

The American Society of Hematology Announces 2016 Scholar Award Recipients

Published on: December 03, 2015

(WASHINGTON, December 3, 2015) – The American Society of Hematology (ASH) today announced the recipients of its 2016 Scholar Awards. One of ASH’s most prestigious award programs, the ASH Scholar Award program financially supports fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators. 

Each Scholar Award provides up to $100,000 for fellows and $150,000 for junior faculty over a two- to three-year period. The program funds hematologists in North America who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH recognizes this year’s corporate supporters: Bayer HealthCare, Celgene Corporation, Genentech, Inc., Gilead Sciences, Inc., Jake Wetchler Foundation for Innovative Pediatric Cancer Research, and Takeda Oncology.

“For 30 years, the ASH Scholar Award program has supported young hematologists, many of whom are now leaders in the field,” said 2015 ASH President David A. Williams, MD, president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Leland Fikes Professor of Pediatrics at Harvard Medical School. “I am very pleased that for the past two years, the ASH Executive Committee has committed additional funding for this very important initiative, allowing us to fund many more scholars. Even with this additional funding, these awards are highly competitive. When talented scholars are provided the resources, time, and support they need to establish independent careers through programs like the ASH Scholar Awards, their careers thrive and they are well-positioned to make a notable impact on research and patient care. I congratulate all of the recipients and hope that this award is as important to their careers as it was to mine many years ago.”

The 2016 Scholar Award recipients are:

Basic Research Fellows

  Connie Arthur, PhD
  Emory University, Atlanta, GA
  Timothy Campbell, MD, PhD
  University of California – San Francisco, San Francisco, CA
  Hamza Celik, PhD
  Washington University School of Medicine, St. Louis, MO
  Timothy Chlon, PhD
  Cincinnati Children’s Hospital, Cincinnati, OH
  Jesús Delgado-Calle, PhD
  Indiana  University School of Medicine, Indianapolis, IN
  Maria Kleppe, PhD
  Memorial Sloan Kettering Cancer Center, New York, NY
  Jana Krietsch, PhD
  University of California – Santa Cruz, Santa Cruz, CA
  Maksim Mamonkin, PhD
  Baylor College of Medicine, Houston, TX
  Julia Maxson, PhD
  Fred Hutchinson Cancer Research Center, Seattle, WA
  Ryohichi Sugimura, MD, PhD
  Boston Children’s Hospital, Boston, MA
  Alberto Yanez-Boyer, PhD
  Cedars Sinai Medical Center, Los Angeles, CA
  Steven Yea, MD, PhD
  University of California – Los Angeles School of Medicine, Los Angeles, CA

Clinical Research Fellows

  Connie Batlevi, MD, PhD
  Memorial Sloan Kettering Cancer Center, New York, NY
  Andrew Branagan, MD
  Yale School of Medicine, New Haven, CT
  Brian Parkin, MD
  University of Michigan, Ann Arbor, MI

Basic Junior Faculty

  Shannon Carty, MD
  University of Pennsylvania, Philadelphia, PA
  Rikhia Chakraborty, PhD
  Baylor College of Medicine, Houston, TX
  Satiro De Oliveira, MD
  University of California – Los Angeles, Los Angeles, CA
  Joji Fujisaki, MD, PhD
  Columbia University, New York, NY
  Malay Haldar, MD, PhD
  University of Pennsylvania, Philadelphia, PA
  Sang Min, MD, PhD
  University of Pennsylvania, Philadelphia, PA
  Stephen Oh, MD, PhD
  Washington University School of Medicine, St. Louis, MO
  Qin Qin, PhD
  The Johns Hopkins University, Baltimore, MD
  Christopher Sturgeon, PhD
  Washington University School of Medicine, St. Louis, MO
  Owen Tamplin, PhD
  Boston Children’s Hospital/Harvard Medical School, Boston, MA
  Valeria Visconte, PhD
  Cleveland Clinic, Cleveland, OH
  Pamela Wenzel, PhD
  The University of Texas Medical School at Houston, Houston, TX

Clinical Junior Faculty 

  M. Paula Aristizabal, MD
  University of California – San Diego, San Diego, CA
  Jonathon Cohen, MD
  Emory University, Atlanta, GA
  Amy Sobota, MD, MPH
  Boston University School of Medicine, Boston, MA

Joanne Levy, MD, Memorial Award for Outstanding Achievement

Omar Abdel-Wahab, MD, of Memorial Sloan Kettering Cancer Center in New York, NY, will receive the 2015 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy, MD, who passed away in 2004, and is presented to the current ASH Scholar with the highest-scoring abstract for the ASH annual meeting, as determined by the appointed abstract reviewers. 

Dr. Abdel-Wahab received his medical degree from Duke University School of Medicine and is currently an Assistant Attending Physician on the Leukemia Service at Memorial Sloan Kettering Cancer Center and a member of the Human Oncology and Pathogenesis Program. He is being honored for his Plenary abstract (Publication #4), “Therapeutic Targeting of Spliceosomal Mutant Myeloid Leukemias through Modulation of Splicing Catalysis.”

Dr. Abdel-Wahab’s current research focuses on the functional understanding of genetic alterations in patients with chronic myeloid and lymphoid leukemias. Supported by the ASH Scholar Award, Dr. Abdel-Wahab is working to understand the biological and therapeutic significance of epigenetic and transcriptional alterations in patients with myelodysplastic syndromes. In addition, Dr. Abdel-Wahab and his colleagues are investigating therapeutic approaches for selective targeting of splicesomal mutant cancers.

About the American Society of Hematology

The American Society of Hematology (ASH) ( is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood (, the most cited peer-reviewed publication in the field, which is available weekly in print and online.

About the ASH Foundation:

The ASH Foundation ( is dedicated to moving hematology forward through support of research, career development, and quality care and education programs. The ASH Foundation is supported through funding, resources, and leadership provided by ASH, the premier organization for physicians and scientists studying and treating blood disorders, and provides a mechanism for ASH members to give in support of critical programs. Personal donations to the ASH Foundation allow the Society to do more for hematology through the expansion or enhancement of existing programs. 

Alicia Davids, American Society of Hematology; 202-552-4925​

back to top